Terms of Service

Last updated: October 2025

Introduction

These Terms of Service ("Terms") govern your use of the Ban The Cancer mobile application operated by My Dolittle GmbH & Co. KG. By accessing or using our app, you agree to be bound by these Terms.

My Dolittle GmbH & Co. KG

HRA62873B

Kopenhagenerstrasse 30, 10437 Berlin, Germany

Acceptance of Terms

By creating an account and using Ban The Cancer, you acknowledge that you have read, understood, and agree to be bound by these Terms. If you do not agree to these Terms, you may not use the app.

Medical Disclaimer

IMPORTANT: Ban The Cancer is a complementary nutrition support tool and does NOT replace professional medical advice, diagnosis, or treatment.

Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay in seeking it because of information provided by this app. The nutrition recommendations and information provided are based on scientific research but are not a substitute for personalized medical care from your oncologist and healthcare team.

Description of Service

Ban The Cancer provides:

  • AI-powered personalized nutrition plans for cancer patients
  • Therapy-synchronized meal and supplement recommendations
  • Symptom tracking and progress monitoring
  • Smart reminders for meals, medications, and hydration
  • Integration of latest scientific research in cancer nutrition

User Responsibilities

You agree to:

  • Provide accurate and complete health information
  • Consult with your healthcare providers before making dietary changes
  • Update your medical information as your treatment progresses
  • Use the app responsibly and in accordance with medical guidance
  • Maintain the confidentiality of your account credentials

Intellectual Property

All content, features, and functionality of Ban The Cancer, including but not limited to software, algorithms, text, graphics, logos, and data compilations, are the exclusive property of My Dolittle GmbH & Co. KG and are protected by international copyright, trademark, and other intellectual property laws.

Limitation of Liability

To the maximum extent permitted by law, My Dolittle GmbH & Co. KG shall not be liable for any indirect, incidental, special, consequential, or punitive damages resulting from your use or inability to use the app. We do not guarantee specific health outcomes.

In case of medical emergency, always contact your doctor or emergency services immediately. Do not rely on the app for urgent medical situations.

Subscription and Payment

Some features of Ban The Cancer may require a paid subscription. Subscription fees, billing cycles, and cancellation policies will be clearly presented before purchase. You can cancel your subscription at any time through your account settings or app store subscription management.

Termination

We reserve the right to suspend or terminate your access to the app at our discretion, without notice, for conduct that we believe violates these Terms or is harmful to other users, us, or third parties. You may terminate your account at any time by contacting us or using the in-app account deletion feature.

Changes to Terms

We may update these Terms from time to time. We will notify you of any material changes by email or through the app. Your continued use of the app after such changes constitutes your acceptance of the new Terms.

Governing Law

These Terms shall be governed by and construed in accordance with the laws of the Federal Republic of Germany. Any disputes arising from these Terms or your use of the app shall be subject to the exclusive jurisdiction of the courts of Berlin, Germany.

Contact Information

If you have any questions about these Terms, please contact us at:

My Dolittle GmbH & Co. KG

Kopenhagenerstrasse 30

10437 Berlin, Germany

Ban The Cancer

Science-based nutrition support for cancer patients

My Dolittle GmbH & Co. KG

HRA62873B

Kopenhagenerstrasse 30, 10437 Berlin

© 2025 Ban The Cancer. All rights reserved.